Why Lear Corporation LEA Just Dropped 328 What to Watch 20260515 Data Center Water Consumption Strains Rural Communities Sparking Concerns Over Resource Allocation KeyCorp KEY Delivers Q1 2026 Beat EPS 044 vs 042 Expected PSQ Holdings PSQH Stock Analysis 281 Loss Key Levels 20260519 ScottScott Attorneys at Law Launches Investigation Into Via Transportation VIA Over Possible Securities Law Violations Goldman Sachs Secures Lead Role in Potential SpaceX IPO Sources Suggest The Hidden Cognitive Bias Behind 70 of Corporate Transformation Failures Anika ANIK Delivers Q1 2026 Beat EPS 027 vs 016 Expected Wall Street Rallies Dow Jones Hits Record High on Middle East Ceasefire Hopes Robotic Automation Could Reshape Global Garment Manufacturing Microsofts GitHub Gains Users but Faces Outages and Competition in AIPowered Coding Market SP 500 Edges Higher as Healthcare and Technology Lead Communication Services Lags Zscaler Posts Revenue and Cash Flow Growth in Q3 FY2026 Despite Net Loss Natural Gas Futures Decline as Weather Forecasts Suggest Milder Conditions BCAX Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline Profound Medical Q1 2026 Earnings EPS Beats Estimates Stock Declines CQP Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Operational Headwinds Weigh GOTU Q4 2025 Earnings EPS Beat Estimates by 419 Amid Challenging Environment VOXR Q1 2026 Earnings Massive EPS Surprise Drives Interest Yet Stock Falters Micron Market Cap Reaches 1 Trillion Milestone Barrons Reports FNLC Q1 2026 Earnings Modest Performance Amid Narrowing Margins Gold Prices Decline on MCX Amid Stronger Dollar and Inflation Concerns Pediatrix Medical Group MD Q1 2026 Earnings EPS Beats Estimates by Nearly 13 as Stock Declines GNSS Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Discrepancy ING Q1 2026 Earnings EPS Beats Estimates Modestly Shares Edge Higher GMED Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response ABCB Q1 2026 Earnings EPS Beats Estimates by 257 Amid Stable Market Response Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues